Middle East & Africa Cough Drops Market Report (2021-2031) by Scope, Segmentation, Dynamics, and Competitive Analysis

The Middle East and Africa (MEA) cough drops market is projected to grow from US$ 89.26 million in 2023 to US$ 136.27 million by 2031, reflecting a compound annual growth rate (CAGR) of 5.4% during this period.

Executive Summary and Market Analysis

The MEA cough drops market is experiencing steady growth, influenced by various factors including climate-related health issues, evolving consumer preferences, and enhanced access to over-the-counter healthcare products. The region's dry and dusty conditions often lead to throat and respiratory discomfort, driving the demand for lozenges that provide quick relief. Traditional remedies remain significant, especially in cultures that favor herbal medicine, with popular ingredients such as black seed, honey, and eucalyptus. While international brands are present, local manufacturers often dominate by offering products that cater to regional tastes. The rise of urbanization, the expansion of pharmacy networks, and the increasing adoption of e-commerce have further improved market accessibility. Additionally, heightened health awareness post-pandemic has spurred interest in immune-supportive formulations. Although the market is still developing, it holds considerable long-term potential as healthcare awareness and infrastructure continue to improve.

Market Segmentation Analysis

The MEA cough drops market can be segmented by product type, application, and distribution channel:

• By Product: The market is divided into gluten-free, sugar-free, and other categories. In 2023, sugar-free cough drops accounted for the largest market share.
• By Application: The market is categorized into adult and children segments, with adults holding a larger share in 2023.
• By Distribution Channel: The market is split into offline and online channels, with offline sales dominating in 2023. The offline segment includes retail pharmacies, supermarkets or hypermarkets, and hospital pharmacies.

Market Outlook

The rise of digital platforms has enabled manufacturers to effectively reach their target audiences through social media and online marketing campaigns. Collaborations with health and wellness influencers are seen as effective strategies to enhance brand credibility and visibility. For instance, in October 2021, HALLS launched its HALLS minis Sugar-Free Cough Drops, featuring a partnership with sportscaster Joe Buck, which included promotional activities on Cameo, a platform connecting fans with celebrities. In October 2023, HALLS collaborated with Grammy-nominated rapper Latto to refresh motivational phrases on their cough drop wrappers.

Brands are also focusing on creating informative content that highlights product benefits and health topics, which helps build consumer loyalty by establishing trust. Furthermore, manufacturers are utilizing data analytics to tailor advertising campaigns to specific demographics, such as millennials who prefer natural ingredients in their medications. Targeted advertising during peak respiratory illness seasons can significantly boost sales, as campaigns emphasizing the effectiveness of cough drops during flu season can attract more consumers. Thus, innovative marketing strategies and data analytics are becoming crucial growth trends in the cough drops market.

Country Insights

The MEA cough drops market includes key countries such as Saudi Arabia, South Africa, the UAE, and other regions in the Middle East and Africa. South Africa held the largest market share in 2023. The increasing prevalence of respiratory illnesses, including allergies and flu, has led consumers to seek over-the-counter relief options like cough drops. Public health initiatives aimed at raising awareness about respiratory health have also contributed to the growing recognition of cough remedies. Improved accessibility of cough drops through various retail channels, including pharmacies, supermarkets, and online platforms, has enhanced consumer reach for market players in South Africa. Additionally, the trend of self-medication, particularly among younger consumers, is driving the acceptance and use of cough drops in the country.

Company Profiles

Key players in the MEA cough drops market include Bliss GVS Pharma Ltd, Cipla Ltd, Gepach International, GSK Plc, Mondelez International Inc, Reckitt Benckiser Group Plc, Ricola, Sanofi SA, The Procter & Gamble Co, and Thornton & Ross, among others. These companies are pursuing various strategies such as expansion, product innovation, and mergers and acquisitions to deliver innovative products and increase their market share.

Reasons to Buy

• Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the Middle East & Africa cough drops market.
• Highlights key business priorities to assist companies to realign their business strategies.
• The key findings and recommendations highlight crucial progressive industry trends in the Middle East & Africa cough drops market, thereby allowing players across the value chain to develop effective long-term strategies.
• Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
• Scrutinize in-depth Middle East & Africa market trends and outlook coupled with the factors driving the Middle East & Africa cough drops market, as well as those hindering it.
• Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing, and distribution.